Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22554727 | 0.98 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22554699 | 0.98 | ALDH1A1 (0.67) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL1918559 | 0.89 | ALDH1A1 (0.54) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL8954034 | 0.87 | ALDH1A1 (0.82) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22517389 | 0.87 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL22554778 | 0.85 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL9326316 | 0.84 | ALDH1A1 (0.54) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| Hydrogen Peroxide SCHEMBL710551 | 0.84 | ALDH1A1 (0.88) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| Hydrogen Peroxide SCHEMBL2233709 | 0.84 | ALDH1A1 (0.88) | ALDH1A1CYP3A4TDP1TSHRTP53 | |
| SCHEMBL1866504 | 0.84 | ALDH1A1 (1.00) | ALDH1A1CYP3A4TDP1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110339862-A | A kind of alpha-diimine palladium catalyst and preparation method thereof that contraposition phenyl replaces | 江苏高科石化股份有限公司 | 2019-10-18 | — | — | CN | claimed |
| EP-4471041-A2 | MOLECULAR ALIGNMENT OF HOMOLEPTIC IRIDIUM PHOSPHORS | University of Southern California (US) | 2024-12-04 | — | — | EP | disclosed |
| EP-4112701-B1 | MOLECULAR ALIGNMENT OF HOMOLEPTIC IRIDIUM PHOSPHORS | UNIV SOUTHERN CALIFORNIA (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-117624221-A | Aza-binuclear large-volume anionic-cationic complex, and preparation method and application thereof | 中化学科学技术研究有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117447403-A | Alkyl carbene compound, ruthenium complex, and preparation methods and applications thereof | 合肥中科科乐新材料有限责任公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-3792270-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-12-13 | — | — | EP | disclosed |
| EP-3988557-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-11-22 | — | — | EP | disclosed |
| EP-4274405-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2023-11-08 | — | — | EP | disclosed |
| EP-4273206-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | Samsung Electronics Co., Ltd. (KR) | 2023-11-08 | — | — | EP | disclosed |
| US-20230133787-A1 | Molecular Alignment of Homoleptic Iridium Phosphors | THE UNIVERSITY OF SOUTHERN CALIFORNIA | 2023-05-04 | — | — | US | disclosed |
| US-8258308-B2 | Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors | LABORATORIOS ALMIRALL, S.A. (ES) | 2012-09-04 | — | — | US | disclosed |
| CN-102060946-B | N, N coordinated nickel vinyl polymerization catalyst containing phenyl as well as preparation and application | UNIV NORTHWEST NORMAL | 2012-07-11 | — | — | CN | disclosed |
| WO-2012034627-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-03-22 | — | — | WO | disclosed |
| EP-1614410-B1 | Dental materials polymerizable by photo-induced ring-opening metathesis polymerization of cyclic olefins | IVOCLAR VIVADENT AG (LI) | 2011-08-10 | — | — | EP | disclosed |
| US-7538172-B2 | Dental materials polymerizable by photo-induced ring-opening metathesis polymerization of cyclic olefins | IVOCLAR VIVADENT AG (LI) | 2009-05-26 | — | — | US | disclosed |
| US-20090062498-A1 | NOVEL STRATEGIES, LINKERS AND COORDINATION POLYMERS FOR HIGH-PERFORMANCE SORBENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2009-03-05 | — | — | US | disclosed |
| EP-1614410-A1 | Dental materials polymerizable by photo-induced ring-opening metathesis polymerization of cyclic olefins | Ivoclar Vivadent AG (LI) | 2006-01-11 | — | — | EP | disclosed |
| US-20060004158-A1 | Dental materials polymerizable by photo-induced ring-opening metathesis polymerization of cyclic olefins | IVOCLAR VIVADENT AG (LI) | 2006-01-05 | — | — | US | disclosed |
| US-6235740-B1 | AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS | BRISTOL-MYERS SQUIBB CO. | 2001-05-22 | — | — | US | disclosed |
| CN-1290165-A | Benzothiazole Protein tyrosine kinase inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2001-04-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133787-A1 | Molecular Alignment of Homoleptic Iridium Phosphors | OCIAD1, OCIAD2, OXA1L | ALDH1A1 1713/4885CYP3A4 4095/4885TDP1 1332/4885 |
| US-20090062498-A1 | NOVEL STRATEGIES, LINKERS AND COORDINATION POLYMERS FOR HIGH-PERFORMANCE SORBENTS | ILK, TIMCC, EPCAM | ALDH1A1 4061/4885CYP3A4 3289/4885TDP1 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.